Efficacy Of Furosemide in the Management of Transient Tachypnoea of Newborn
DOI:
https://doi.org/10.61581/MJSP.VOL06/01/08Keywords:
Continuous Positive Airway Pressure, Furosemide, Oxygen inhalation therapy, Transient Tachypnea of the NewbornAbstract
Objective: To see the efficacy of intravenous Furosemide in the management of transient tachypnoea of newborn.
Methodology: This study was conducted at the Department of Paediatrics, Fauji Foundation Hospital Rawalpindi from August to December 2024. Neonates with 34 to 40 weeks of gestation diagnosed with TTN and requiring CPAP to maintain oxygen saturation > 90% were included. Neonates born with congenital malformations, systemic infection, requiring mechanical ventilation and intubation were excluded. Intravenous furosemide was administered to Group A, while Group B was managed conservatively and normal saline as a placebo was used. Following the start of therapy each patient will be monitored to assess the efficacy of the therapy, in terms of length of hospital stay and duration of oxygen therapy.
Results: One hundred and seventy-two (n=172) patients had a mean gestational age of 38.45±1.07 weeks. The respiratory rate at admission was 84.75±15.49 breaths/minute in Group A and 82.69±13.89 breaths/minute in Group B with no statistical difference (p=0.403). Post-intervention in Group A the respiratory rate was 46.61±4.97 breaths/minute and in Group B it was 51.24±4.27 breaths/minute (p<0.001). The control group required longer mean oxygen therapy than the Furosemide group. Similarly, the mean length of hospital stay was also higher in Group B than in Group A (p<0.001).
Conclusion: The treatment with furosemide significantly improved the transient tachypnoea of newborns but it also decreased the duration of oxygen therapy and length of hospital stay.
Downloads
References
1. Alhassen Z, Vali P, Guglani L, Lakshminrusimha S, Ryan RM. Recent Advances in Pathophysiology and Management of Transient Tachypnea of Newborn. J Perinatol. 2021;41(1):6-16. doi: 10.1038/s41372-020-0757-3.
2. Chavan S, Malwade SD, Kumari S, Garud BP, Agarkhedkar S. Incidence, Clinical Features, and Outcomes of Transient Tachypnea of the Newborn at a Tertiary Care Center in Western India. Cureus. 2022;14(4):e23939.
3. Çelik Y, Kahvecioğlu D, Ece İ, Atik F, Çetinkaya AK, Taşar MA. New parameters on prediction of severity of transient tachypnea of the newborn. Turk J Med Sci. 2022;52(4):1006-1012.
4. Cevik I, Er I, Gunlemez A. Factors Affecting Lung Function in Preschool Children with a History of Transient Tachypnea of the Newborn. Iran J Pediatr. 2024;34(6):e138368.
5. Ibrahim M, Omran A, Abdallah NB, Ibrahim M, El-Sharkawy S. Lung ultrasound in early diagnosis of neonatal transient tachypnea and its differentiation from other causes of neonatal respiratory distress. J Neonatal Perinatal Med. 2018;11(3):281-87.
6. Mohammed AK, Madkour MA, Hassanien HM. Furosemide: Would it help to improve the lungs as evaluated by sonography and compliance during aortic coarctation surgery. Ann Card Anaesth. 2019;22(3):254-259.
7. Lewis V, Whitelaw A. Furosemide for transient tachypnea of the newborn. Cochrane Database Syst Rev. 2002;(1):CD003064.
8. Ali S, Razzaq A, Shah SA, Ahmad Z. Intravenous Furosemide in the Management of Transient Tachypnea of Newborn. Pak Armed Forces Med J. 2023;73(3):666-9.
9. Khushdil A, Ahmed Z, Ahmed M, Nazir S, Waqar T. Effects of Salbutamol and Furosemide in The Treatment of Transient Tachypnea of Newborn - A Randomized Controlled Trial. Pak Armed Forces Med J. 2022;72(1):101-04.
10. Celebi MY, Alan S, Kahvecioglu D, Cakir U, Yildiz D, Erdeve O, et al. Impact of Prophylactic Continuous Positive Airway Pressure on Transient Tachypnea of the Newborn and Neonatal Intensive Care Admission in Newborns Delivered by Elective Cesarean Section. Am J Perinatol. 2016;33(1):99-106.
11. Golshantafti M, Yavari T, Afrand M. Risk of Wheezing Attacks in Infants With Transient Tachypnea Newborns. Iran J Pediatr. 2016;26(1):e2295.
12. Hooper SB, Te Pas AB, Kitchen MJ. Respiratory transition in the newborn: a three-phase process. Arch Dis Child Fetal Neonatal Ed. 2016;101(3):F266-71.
13. McGillick EV, Lee K, Yamaoka S, Te Pas AB, Crossley KJ, Wallace MJ, et al. Elevated airway liquid volumes at birth: a potential cause of transient tachypnea of the newborn. J Appl Physiol (1985). 2017;123(5):1204-1213.
14. Ali S, Razzaq A, Shah SA, Ahmad Z. Intravenous Furosemide in the Management of Transient Tachypnea of Newborn. Pak Armed Forces Med J 2023; 73(3): 666-669.
15. Buchiboyina A, Jasani B, Deshmukh M, Patole S. Strategies for managing transient tachypnoea of the newborn-a systematic review. J Matern Fetal Neonatal Med 2017; 30(13): 1524-1532.
16. Gupta N, Bruschettini M, Chawla D. Fluid restriction in the management of transient tachypnea of the newborn. Cochrane Database Syst Rev. 2021;2(2):CD011466.
17. Ali HM, Adnan M, Hussain E, Asif A, Shoaib M, Yasmin S, et al. Efficacy of salbutamol and lasix in early resolution of transient tachypnea of newborn. J PopulTher Clin Pharmacol.2024; 31(7), 1383-88.
18. Kassab M, Khriesat WM, Bawadi H, Anabrees J. Furosemide for transient tachypnoea of the newborn. Cochrane Database Syst Rev. 2015;(11):CD003064.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hafsa Arshad, Awais Tahir, Bilal Akhlaq, Umair Anees, Hafiz Abdul Quddus, Muhammad Iqbal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
